10 New Endocrinology Drugs in 2019

Slideshow

In this slideshow, we review 10 new drugs or new indications for diabetes and other endocrine conditions.

In this slideshow, we review 10 new drugs or new indications for diabetes and other endocrine conditions.

Recent Videos
Brendon Neuen, MBBS, PhD | Credit: X.com
HCPLive Five at ADA 2024 | Image Credit: HCPLive
Ralph DeFronzo, MD | Credit: UT San Antonio
Timothy Garvey, MD | Credit: University of Alabama at Birmingham
Atul Malhotra, MD | Credit: Kyle Dykes; UC San Diego Health
Alexandra Louise Møller, MS, PhD | Credit: LinkedIn
A panel of 5 experts on Cushing's syndrome
A panel of 5 experts on Cushing's syndrome
Optimizing Diabetes Therapies with New Classifications
Vlado Perkovic, MBBS, PhD | Credit: George Institute of Global Health
Related Content
Alie Rezaie, MD | Credit: Cedars-Sinai

Surge in New GLP-1 Prescriptions Driven by Semaglutide's Popularity, Study Shows

Patrick Campbell
July 22nd 2024
Article
John Buse, MD, PhD | Credit: UNC School of Medicine

Diabetes Dialogue: CATALYST Trial and Hypercortisolism in T2D, with John Buse, MD, PhD

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES;Natalie Bellini, DNP, FNP-BC, BC-ADM, CDCE
July 15th 2024
Podcast
Alex Henney, MBChB | Credit: Alex Henney on LinkedIn

Hyperandrogenism Linked to Increased Risk of MASLD in PCOS

Abigail Brooks, MA
July 17th 2024
Article
Diabetes Dialogue: ADA 2024 Diabetes Technology Recap

Diabetes Dialogue: ADA 2024 Diabetes Technology Recap

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES;Natalie Bellini, DNP, FNP-BC, BC-ADM, CDCE
July 3rd 2024
Podcast
Morten Schou, MD, PhD | Credit: LinkedIn

Semaglutide Can Preserve, Possibly Improve, NYHA Functional Class in Obesity-Related HFpEF

Patrick Campbell
July 11th 2024
Article
Brendon Neuen, MBBS, PhD | Credit: X.com

SGLT2 Inhibitor, GLP-1 RA Combination Improves Cardiovascular, Kidney Outcomes in Diabetes

Abigail Brooks, MA
July 9th 2024
Article
© 2024 MJH Life Sciences

All rights reserved.